| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus
|
Fish, Rebecca
|
|
2018
|
3 |
12 |
p. 865-873
|
artikel
|
| 2 |
American College of Gastroenterology Annual Scientific Meeting 2018
|
Thorley, Jennifer
|
|
2018
|
3 |
12 |
p. 821
|
artikel
|
| 3 |
An unusually pigmented colon
|
Morgan, James A
|
|
2018
|
3 |
12 |
p. 884
|
artikel
|
| 4 |
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial
|
Romera, Alvaro
|
|
2018
|
3 |
12 |
p. 845-855
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2018; published online Sept 24. http://dx.doi.org/10.1016/S2468-1253(18)30269-3
|
|
|
2018
|
3 |
12 |
p. e7
|
artikel
|
| 6 |
Drug pricing: still a barrier to elimination of HCV
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
3 |
12 |
p. 813
|
artikel
|
| 7 |
Elsie Widdowson: food for thought
|
Burki, Talha Khan
|
|
2018
|
3 |
12 |
p. 823
|
artikel
|
| 8 |
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis
|
Chadi, Sami A
|
|
2018
|
3 |
12 |
p. 825-836
|
artikel
|
| 9 |
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies
|
van Tilborg, Marjolein
|
|
2018
|
3 |
12 |
p. 856-864
|
artikel
|
| 10 |
HCV core antigen: toward elimination of nucleic acid testing?
|
Lemoine, Maud
|
|
2018
|
3 |
12 |
p. 817-818
|
artikel
|
| 11 |
Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs
|
Chhatwal, Jagpreet
|
|
2018
|
3 |
12 |
p. 819
|
artikel
|
| 12 |
Imipramine for functional dyspepsia: a 60-year journey
|
Kanno, Takeshi
|
|
2018
|
3 |
12 |
p. 815-817
|
artikel
|
| 13 |
Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial
|
Cheong, Pui Kuan
|
|
2018
|
3 |
12 |
p. 837-844
|
artikel
|
| 14 |
Phage display pioneers awarded Nobel Prize
|
Burki, Talha Khan
|
|
2018
|
3 |
12 |
p. 820
|
artikel
|
| 15 |
Research in brief
|
Baker, Holly
|
|
2018
|
3 |
12 |
p. 822
|
artikel
|
| 16 |
Resolving gastric cancer aetiology: an update in genetic predisposition
|
Lott, Paul C
|
|
2018
|
3 |
12 |
p. 874-883
|
artikel
|
| 17 |
Understanding the gut–brain axis
|
Cooper, Ashley
|
|
2018
|
3 |
12 |
p. 824
|
artikel
|
| 18 |
Waiting for the ferry
|
Wortley, Chris
|
|
2018
|
3 |
12 |
p. 824
|
artikel
|
| 19 |
Watch and wait in rectal cancer: is it time to subclassify cT3?
|
Glynne-Jones, Rob
|
|
2018
|
3 |
12 |
p. 814-815
|
artikel
|
Tijdschrift beschrijving